Tokyo, Feb. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060750) titled 'The effect of alpha-linolenic acid intake on blood pressure reduction - A systematic review' on Feb. 26.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yakujihou Marketing Jimusho
Condition:
Condition - Healthy adults who are not suffering from any illness
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate the effect of alpha-linolenic acid intake on blood pressure reduction.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Individuals with high-normal blood pressure and those with stage I hypertension
Key exclusion criteria - Individuals under 18 years old, pregnant women, and individuals with illnesses (excluding those with stage I hypertension)
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 02 Day
Anticipated trial start date - 2026 Year 02 Month 26 Day
Last follow-up date - 2026 Year 05 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069515
Disclaimer: Curated by HT Syndication.
